TY - JOUR
T1 - Lessons learned before and after cardiomyoplasty
T2 - Risk sensitive patient selection and post procedure quality of life
AU - Furnary, Anthony P.
AU - Swanson, Jeffrey S.
AU - Grunkemeier, Gary
AU - Starr, Albert
PY - 1996
Y1 - 1996
N2 - Background: This paper unveils some of the clinical lessons we have learned from caring for cardiomyoplasty patients over the past 7 years. We examine both the clinical and scientific rationale for expanding the time frame of 'procedural mortality' from 30 days to 90 days. Methods: Utilizing this definition of procedural mortality, preoperative patient variables were applied to postoperative patient outcomes in order to develop a risk sensitive method of patient selection. Preoperative atrial fibrillation, elevated pulmonary capillary wedge pressure, decreased peak oxygen consumption, and the requirement of intra-aortic balloon pump at the time of cardiomyoplasty, were all found to be independent risk factors for early death following cardiomyoplasty. Results: This analysis, which has been previously published, is reviewed and enhanced with the mathematical equations for duplicating these relative risk calculations. The mathematical model presented herein allows a method of risk stratification, which obviates the need for randomized congestive heart failure controls in the future. In the absence of a statistically regulated control population, we also examine the 1-year clinical outcomes of the nonrandomizd control group of patients, who were followed during the North American FDA Phase II Cardiomyoplasty Trial. Conclusions: This quality of life comparison with cardiomyoplasty patients at 1 year revealed a significant decrease in intensive care unit patient-days, a significant increase in activity of daily living score, and a significant improvement in New York Heart Association functional class as compared to control.
AB - Background: This paper unveils some of the clinical lessons we have learned from caring for cardiomyoplasty patients over the past 7 years. We examine both the clinical and scientific rationale for expanding the time frame of 'procedural mortality' from 30 days to 90 days. Methods: Utilizing this definition of procedural mortality, preoperative patient variables were applied to postoperative patient outcomes in order to develop a risk sensitive method of patient selection. Preoperative atrial fibrillation, elevated pulmonary capillary wedge pressure, decreased peak oxygen consumption, and the requirement of intra-aortic balloon pump at the time of cardiomyoplasty, were all found to be independent risk factors for early death following cardiomyoplasty. Results: This analysis, which has been previously published, is reviewed and enhanced with the mathematical equations for duplicating these relative risk calculations. The mathematical model presented herein allows a method of risk stratification, which obviates the need for randomized congestive heart failure controls in the future. In the absence of a statistically regulated control population, we also examine the 1-year clinical outcomes of the nonrandomizd control group of patients, who were followed during the North American FDA Phase II Cardiomyoplasty Trial. Conclusions: This quality of life comparison with cardiomyoplasty patients at 1 year revealed a significant decrease in intensive care unit patient-days, a significant increase in activity of daily living score, and a significant improvement in New York Heart Association functional class as compared to control.
UR - http://www.scopus.com/inward/record.url?scp=0029848897&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029848897&partnerID=8YFLogxK
U2 - 10.1111/j.1540-8191.1996.tb00040.x
DO - 10.1111/j.1540-8191.1996.tb00040.x
M3 - Article
C2 - 8889881
AN - SCOPUS:0029848897
SN - 0886-0440
VL - 11
SP - 200
EP - 206
JO - Journal of Cardiac Surgery
JF - Journal of Cardiac Surgery
IS - 3
ER -